When cells multiply and migrate, they can be compressed and their nucleus may break open. This phenomenon causes DNA damage. Scientists from the CNRS, Institut Curie and INSERM have now shown that this facilitates the spread ...
Sep 23, 2021
0
25
Circulating tumor cells (CTCs) with stem cell features use the adhesive protein ICAM1 to facilitate formation of CTC clusters, which can travel from primary tumors to other organs in the body, according to a Northwestern ...
Sep 23, 2021
0
21
Breast cancer patients whose cancer spreads to the brain may soon have new treatment options, thanks to research led by CU Cancer Center member Diana Cittelly, Ph.D.
Sep 20, 2021
0
2
Cancer cells proliferate despite a myriad of stresses—from oxygen deprivation to chemotherapy—that would kill any ordinary cell. Now, researchers at UC San Francisco have gained insight into how they may be doing this ...
Sep 20, 2021
0
83
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that treating women with HER2 positive metastatic breast cancer with the HER2-targeting antibody-drug conjugate trastuzumab deruxtecan (T-DXd) ...
Sep 18, 2021
0
58
For breast cancer patients, standard-of care therapies become drastically less effective if their tumor has spread to other parts of the body, such as the lung.
Sep 17, 2021
0
68
Leading scientists have identified a possible link between antibiotic use and the speed of breast cancer growth in mice, and identified a type of immune cell that could be targeted to reverse it.
Sep 16, 2021
0
35
Researchers from the Case Comprehensive Cancer Center uncovered the potentially important role of the protein-coding gene, MYO10, in tumor development and immune therapy response. Their findings were published today in Science ...
Sep 15, 2021
0
65
Using a virus that grows in black-eyed pea plants, nanoengineers at the University of California San Diego developed a new treatment that could keep metastatic cancers at bay from the lungs. The treatment not only slowed ...
Sep 14, 2021
0
248
A team led by the Garvan Institute of Medical Research has revealed a new approach for classifying breast cancer subtypes based on their cell profile, which could help personalize treatments for patients.
Sep 13, 2021
0
61
